Transarterial chemoembolization (TACE) has become one of the most effective minimally invasive treatments for cancer, especially for patients with liver tumors that cannot be removed surgically. By combining targeted chemotherapy with embolization, TACE offers focused tumor control while minimizing side effects on healthy organs.
In 2026, German hospitals will continue to lead in refining this advanced treatment, offering international patients innovative interventional oncology procedures. Booking Health announces expanded access to this therapy, connecting patients worldwide to specialized TACE programs in Germany.
What TACE Is and How It Works
TACE employs a two-step approach to treat tumors with an arterial blood supply. The first step involves making a small puncture in the groin or wrist that is threaded with a thin catheter, passed through the blood vessels to the artery feeding the cancer. After the catheter is in place, it is infused with a mixture of chemotherapy drugs and particulates that act as embolization therapy. The chemotherapy drugs act locally, while the embolic drug occludes the blood supply to the tumor, thereby starving it of necessary oxygen. Treatment effects are localized, and the order of the chemotherapy drugs is not compromised with respect to systemic chemotherapy.
Which Cancers Can Be Treated With TACE?
Although most widely known for liver cancer, TACE is also applied in other cancers with a localized blood supply.
Common indications include:
- Primary liver cancer (hepatocellular carcinoma)
- Secondary liver metastases (from colon, breast, or stomach cancer)
- Kidney cancer
- Neuroendocrine tumors
- Selected cases of pancreatic, lung, bladder, prostate, or ovarian cancers
TACE vs Conventional Chemotherapy
| Aspect | Systemic Chemotherapy | Transarterial Chemoembolization (TACE) |
| Delivery method | Circulates throughout the body | Directly via the catheter into the tumor |
| Side effects | High toxicity (fatigue, nausea, immune suppression) | Mild, mostly local discomfort |
| Effectiveness | Generalized effect, less targeted | Focused tumor control, repeatable |
| Hospital stay | Multiple cycles over months | Usually outpatient or short stay |
Why Germany Leads in TACE
Germany is one of the leading treatment destinations when it comes to TACE. The advantage of Germany is in the combination of modern technologies with modern multidisciplinary care. Hospitals in Germany have modern high-resolution imaging, precision microcatheters, and embolizants for each particular area of treatment. The therapies are performed and planned through the close cooperation of oncologists, hepatologists and interventional radiologists, with the highest safety precautions in place. For international patients Germany offers transparent price levels, which usually range from 6500 € to 24000 € per TACE cycle, depending on the complexity of the tumors and the number of TACE cycles required.
Why Patients Benefit From TACE in Germany
Patients undergoing transarterial chemoembolization (TACE) in Germany experience improved survival and quality of life. Large clinical studies have demonstrated that TACE can improve median survival significantly in liver cancer patients compared to untreated cases.
Because TACE is a repeatable and well-tolerated procedure, it is commonly included in long-term therapy plans for patients who are not candidates for surgical intervention. There is considerable appreciation on the part of patients for this rapid improvement, which allows a quick return to normal conditions compared to traditional cancer treatment methods.
Booking Health opens the way for patients to receive appointments at the world-famous German hospitals where TACE is performed with the use of the latest imaging studies and rigid safety measures. Benefits include:
- Minimally invasive techniques – No abdominal incisional surgery means recovery is faster
- Localized treatment of tumor – The chemotherapeutic agent is administered directly to the tumor
- Lower systemic toxicity – Produces fewer side effects than routine chemotherapy
- Repeatable procedures – TACE can be repeated many times if necessary.
- Flexible availability – Effective combination therapies will be available with other therapeutic measures, such as immunotherapy or ablation techniques.
Booking Health: Offering Access to TACE Programs in Germany
Booking Health is a trusted international medical tourism company that connects patients to top cancer hospitals in Germany. By coordinating access to TACE programs, the company ensures that patients benefit from advanced treatments, expert teams, and smooth logistical support from start to finish.
Services include:
- Full medical report evaluation and treatment planning.
- Direct booking with hospitals specializing in interventional oncology.
- Support with visas, travel, and accommodation.
- Translation of medical documents.
- 24/7 assistance from a personal coordinator.
- Transparent, fixed pricing with no hidden fees.
With over 12 years of experience, Booking Health ensures that patients receive not only advanced cancer care but also comprehensive support throughout their medical journey.
Contact Booking Health today to receive access to Germany’s leading hospitals for transarterial chemoembolization and begin your treatment with world-class cancer specialists.